Trials / Conditions / Stage III Hilar Cholangiocarcinoma AJCC v8
Stage III Hilar Cholangiocarcinoma AJCC v8
3 registered clinical trials studyying Stage III Hilar Cholangiocarcinoma AJCC v8.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma NCT06420349 | Mayo Clinic | Phase 1 |
| Active Not Recruiting | Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A Co NCT05564403 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangio NCT06178588 | University of Kansas Medical Center | Phase 2 |